Joanne Jeter

1.1k total citations
37 papers, 675 citations indexed

About

Joanne Jeter is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Joanne Jeter has authored 37 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 13 papers in Genetics and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Joanne Jeter's work include BRCA gene mutations in cancer (12 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Genetic factors in colorectal cancer (6 papers). Joanne Jeter is often cited by papers focused on BRCA gene mutations in cancer (12 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Genetic factors in colorectal cancer (6 papers). Joanne Jeter collaborates with scholars based in United States, Mexico and Germany. Joanne Jeter's co-authors include David S. Alberts, Lisa M. Hess, Marge Benham‐Hutchins, Mok Oh, Ivo Abraham, Ali McBride, Stephen B. Gruber, Jennifer Martin, Wendy Kohlmann and Sandipan Bhattacharjee and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Joanne Jeter

32 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanne Jeter United States 14 349 170 154 126 117 37 675
Domenico Sergi Italy 16 359 1.0× 96 0.6× 178 1.2× 82 0.7× 157 1.3× 54 796
Marilyn Gordon Canada 13 158 0.5× 75 0.4× 265 1.7× 57 0.5× 47 0.4× 17 564
Salma Butt Sweden 12 203 0.6× 100 0.6× 90 0.6× 108 0.9× 145 1.2× 21 417
Radosław Mądry Poland 16 513 1.5× 131 0.8× 221 1.4× 60 0.5× 68 0.6× 85 814
Kelly Townsend United Kingdom 10 411 1.2× 186 1.1× 887 5.8× 273 2.2× 120 1.0× 12 1.3k
T. Gulliford United Kingdom 8 230 0.7× 68 0.4× 134 0.9× 130 1.0× 96 0.8× 10 456
Christian Dannecker Germany 12 118 0.3× 62 0.4× 116 0.8× 67 0.5× 74 0.6× 58 459
Jonathan S.T. Sham Hong Kong 17 555 1.6× 78 0.5× 341 2.2× 100 0.8× 163 1.4× 32 1.1k
Susan Cottrell United States 12 118 0.3× 66 0.4× 481 3.1× 30 0.2× 121 1.0× 15 882
Elizabeth Pang Hong Kong 13 229 0.7× 194 1.1× 381 2.5× 55 0.4× 206 1.8× 24 740

Countries citing papers authored by Joanne Jeter

Since Specialization
Citations

This map shows the geographic impact of Joanne Jeter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne Jeter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne Jeter more than expected).

Fields of papers citing papers by Joanne Jeter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne Jeter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne Jeter. The network helps show where Joanne Jeter may publish in the future.

Co-authorship network of co-authors of Joanne Jeter

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne Jeter. A scholar is included among the top collaborators of Joanne Jeter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne Jeter. Joanne Jeter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rybak, Christina, Joanne Jeter, Kevin McDonnell, et al.. (2024). O06: Penetrance and prevalence of CDKN2A pathogenic variants in a large institutional cohort: Scrutinizing the common p.Ile49Thr variant. SHILAP Revista de lepidopterología. 2. 100941–100941.
3.
4.
Maffuz‐Aziz, Antonio, et al.. (2024). Mexican physicians' knowledge and attitudes towards hereditary colorectal cancer risk management.. Journal of Clinical Oncology. 42(16_suppl). e22552–e22552.
5.
McPherson, Jordan P., Magdalena Kovacsovics-Bankowski, Joanne Jeter, et al.. (2023). A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome. Frontiers in Immunology. 14. 1229823–1229823. 16 indexed citations
6.
Ramsey, Mitchell L., Rachel Pearlman, Laith Abushahin, et al.. (2022). Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake. Familial Cancer. 22(1). 91–97. 23 indexed citations
7.
Rogers, Charles R., et al.. (2022). Genetic Evaluation for Hereditary Cancer Syndromes Among African Americans: A Critical Review. The Oncologist. 27(4). 285–291. 12 indexed citations
8.
Oh, Mok, Joanne Jeter, Jennifer Martin, et al.. (2019). The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta‐analysis. The Prostate. 79(8). 880–895. 90 indexed citations
9.
Garcia, Andrew, Joanne Jeter, Ivo Abraham, et al.. (2019). Incidence of Hypersensitivity Reactions to Carboplatin or Paclitaxel in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer With or Without BRCA1 or BRCA2 Mutations. Journal of the Advanced Practitioner in Oncology. 10(5). 428–439. 3 indexed citations
10.
Cuéllar, Luis E., et al.. (2018). Prognostic factors in HIV-positive patients with non-Hodgkin lymphoma: a Peruvian experience. Infectious Agents and Cancer. 13(1). 27–27. 9 indexed citations
11.
Komatsubara, Kimberly M., Joanne Jeter, Richard D. Carvajal, et al.. (2017). Advances in the Treatment of Advanced Extracutaneous Melanomas and Nonmelanoma Skin Cancers. American Society of Clinical Oncology Educational Book. 37. 641–650. 8 indexed citations
12.
Kumar, Abhijeet, et al.. (2017). Tumor microenvironment changes leading to resistance of immune checkpoint inhibitors in metastatic melanoma and strategies to overcome resistance. Pharmacological Research. 123. 95–102. 52 indexed citations
13.
Beasley, Georgia M., Jeffrey VanDeusen, John H. Howard, et al.. (2016). Immune Checkpoint Inhibitor Therapy as a Novel and Effective Therapy for Aggressive Cutaneous Squamous-cell Carcinoma. 1(2). 75–81. 6 indexed citations
14.
Mukherjee, Bhramar, John Oliver DeLancey, Leon Raskin, et al.. (2012). Risk of Non-Melanoma Cancers in First-Degree Relatives of CDKN2A Mutation Carriers. JNCI Journal of the National Cancer Institute. 104(12). 953–956. 34 indexed citations
15.
Jeter, Joanne, Jiali Han, Marı́a Elena Martı́nez, et al.. (2012). Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses’ Health Study. Cancer Causes & Control. 23(9). 1451–1461. 29 indexed citations
16.
Jeter, Joanne, Joseph D. Bonner, Timothy M. Johnson, & Stephen B. Gruber. (2011). Nonsteroidal Anti-Inflammatory Drugs and Risk of Melanoma. Journal of Skin Cancer. 2011. 1–4. 15 indexed citations
17.
Rubenstein, Joel H., Akbar K. Waljee, Joanne Jeter, et al.. (2009). Cost Effectiveness of Ulcerative Colitis Surveillance in the Setting of 5-Aminosalicylates. The American Journal of Gastroenterology. 104(9). 2222–2232. 30 indexed citations
18.
Hess, Lisa M., Joanne Jeter, Marge Benham‐Hutchins, & David S. Alberts. (2008). Factors Associated with Osteonecrosis of the Jaw among Bisphosphonate Users. The American Journal of Medicine. 121(6). 475–483.e3. 86 indexed citations
19.
Harris, Richard E., Joanne Jeter, Paul Chan, et al.. (2005). Using Acupressure to Modify Alertness in the Classroom: A Single-Blinded, Randomized, Cross-Over Trial. The Journal of Alternative and Complementary Medicine. 11(4). 673–679. 21 indexed citations
20.
Kleinhofs, A., R. L. Warner, James M. Lawrence, et al.. (1989). Molecular genetics of nitrate reductase in barley.. 197–211. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Domenico Sergi Breakdown of academic impact, for papers by Marilyn Gordon Breakdown of academic impact, for papers by Salma Butt Breakdown of academic impact, for papers by Radosław Mądry Breakdown of academic impact, for papers by Kelly Townsend Breakdown of academic impact, for papers by T. Gulliford Breakdown of academic impact, for papers by Christian Dannecker Breakdown of academic impact, for papers by Jonathan S.T. Sham Breakdown of academic impact, for papers by Susan Cottrell Breakdown of academic impact, for papers by Elizabeth Pang
Rankless by CCL
2026